AZN: AstraZeneca PLC Stocks News on September 1, 2025

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial

AZN

Business Wire

a day ago

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial

AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results

AZN

Investor's Business Daily

a day ago

AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension Results

The Bull Case For Legend Biotech (LEGN) Could Change Following Appointment of CFO With Global Pharma Expertise

AZN

Simply Wall St.

2 days ago

The Bull Case For Legend Biotech (LEGN) Could Change Following Appointment of CFO With Global Pharma Expertise

AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025

AZN

Insider Monkey

4 days ago

AstraZeneca PLC (AZN) Oncology Sales Hit $12B in H1 2025

Regeneron tees up myasthenia gravis drug approval after Phase III victory

AZN

Clinical Trials Arena

4 days ago

Regeneron tees up myasthenia gravis drug approval after Phase III victory

AZN

Business Wire

5 days ago

Box to Present at Investor Conference

HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries

AZN

GlobeNewswire

5 days ago

HER2+ Breast Cancer Clinical Trials Analysis Report 2025 - Enhance Your Understanding of Trial Counts and Enrollment Trends Across G7 & E7 Countries

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

AZN

GlobeNewswire

5 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

AZN

GlobeNewswire

5 days ago

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More

AZN

GlobeNewswire

5 days ago

Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030

AZN

GlobeNewswire

6 days ago

Controlled Release Drug Delivery Market and Clinical Pipeline Report: A $90 Billion Opportunity in Controlled Release Drug Delivery by 2030

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

AZN

GlobeNewswire

7 days ago

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China

AZN

Pharmaceutical Technology

7 days ago

Daiichi Sankyo and AstraZeneca’s Datroway receives approval in China

AZN

Simply Wall St.

9 days ago

AstraZeneca (LSE:AZN) Joins Forces To Launch Sovereign AI Supercomputer With Sferical AI

AZN

Reuters

10 days ago

Sweden's Wallenberg groups launch joint AI company

ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment

AZN

Exec Edge

10 days ago

ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment

AZN

Morningstar Research

10 days ago

Analyst Report: Ionis Pharmaceuticals, Inc.

Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu Vaccine

AZN

Business Wire

10 days ago

Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu Vaccine

J&J to invest $2 billion to boost US manufacturing as drug tariffs loom

AZN

Reuters

11 days ago

J&J to invest $2 billion to boost US manufacturing as drug tariffs loom

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

AZN

Zacks

11 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

The Quantum Computing Race Is On: These 2 Stocks Appear Poised to Lead

AZN

Barchart

12 days ago

The Quantum Computing Race Is On: These 2 Stocks Appear Poised to Lead

AlzeCure Appoints Cecilia Wadell as New Head of Development

AZN

ACCESS Newswire

12 days ago

AlzeCure Appoints Cecilia Wadell as New Head of Development

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

AZN

Zacks

12 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Strategic Partnerships Power Tempus AI's Healthcare Expansion

AZN

Zacks

12 days ago

Strategic Partnerships Power Tempus AI's Healthcare Expansion

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

AZN

PR Newswire

13 days ago

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market

AZN

GlobeNewswire

13 days ago

Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

AZN

Zacks

13 days ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

AZN

MT Newswires

13 days ago

Legend Biotech Names Carlos Santos CFO

AZN

MT Newswires

14 days ago

FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval

AZN

MT Newswires

14 days ago

FibroGen Receives Chinese Regulator's Approval for Sale of Subsidiary to AstraZeneca

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

AZN

GlobeNewswire

14 days ago

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

AZN

Zacks

14 days ago

The Zacks Analyst Blog Highlights D-Wave Quantum, Rigetti Computing, IonQ, AstraZeneca, AWS and NVIDIA

AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination

AZN

Simply Wall St.

15 days ago

AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination

America’s first needle-free, at-home flu vaccine is now available

AZN

FastCompany

16 days ago

America’s first needle-free, at-home flu vaccine is now available

Quantum Stocks Q2 2025: Are D-Wave, IonQ & Rigetti Funding the Future?

AZN

Zacks

16 days ago

Quantum Stocks Q2 2025: Are D-Wave, IonQ & Rigetti Funding the Future?

AZN

MT Newswires

16 days ago

European Equities Close Mixed in Friday Trading; Swiss GDP Flat in Q2

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

AZN

Zacks

16 days ago

AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AZN

GlobeNewswire

16 days ago

AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update

AZN

MT Newswires

16 days ago

AstraZeneca Launches At-Home Delivery Service for Nasal Spray Flu Vaccine

FLUMIST (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery

AZN

Business Wire

17 days ago

FLUMIST (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth

AZN

GlobeNewswire

18 days ago

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact

AZN

PR Newswire

19 days ago

The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact

Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors

AZN

Business Wire

20 days ago

Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors

AZN

MT Newswires

20 days ago

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana

AZN

Insider Monkey

20 days ago

Revna Biosciences and AstraZeneca Increase Access to Lung Cancer Treatment in Ghana

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

AZN

GlobeNewswire

20 days ago

FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update

IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?

AZN

Zacks

20 days ago

IonQ Stock Surges on Quantum Breakthroughs: More Upside Ahead?

Stuttering Market Research Report 2025-2035 | AstraZeneca, via Alexion, Leads with Strensiq as the First Approved Enzyme Replacement Therapy

AZN

GlobeNewswire

21 days ago

Stuttering Market Research Report 2025-2035 | AstraZeneca, via Alexion, Leads with Strensiq as the First Approved Enzyme Replacement Therapy

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

AZN

GlobeNewswire

21 days ago

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

LegalZoom (LZ) Climbs to New High as Firm Raises Growth Forecast, Analyst Turns Bullish

AZN

Insider Monkey

22 days ago

LegalZoom (LZ) Climbs to New High as Firm Raises Growth Forecast, Analyst Turns Bullish

Heartflow (HTFL) Soars 66% on IPO on Strong Investor Confidence

AZN

Insider Monkey

22 days ago

Heartflow (HTFL) Soars 66% on IPO on Strong Investor Confidence

Varex Imaging Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

AZN

Simply Wall St.

22 days ago

Varex Imaging Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Energy Fuels Inc. (TSE:EFR) Just Reported And Analysts Have Been Lifting Their Price Targets

AZN

Simply Wall St.

22 days ago

Energy Fuels Inc. (TSE:EFR) Just Reported And Analysts Have Been Lifting Their Price Targets

Block Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

AZN

Simply Wall St.

22 days ago

Block Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Acorn Energy Second Quarter 2025 Earnings: EPS: US$0.29 (vs US$0.11 in 2Q 2024)

AZN

Simply Wall St.

22 days ago

Acorn Energy Second Quarter 2025 Earnings: EPS: US$0.29 (vs US$0.11 in 2Q 2024)

Artivion Second Quarter 2025 Earnings: Beats Expectations

AZN

Simply Wall St.

22 days ago

Artivion Second Quarter 2025 Earnings: Beats Expectations

Is TransAct Technologies Incorporated (NASDAQ:TACT) Potentially Undervalued?

AZN

Simply Wall St.

22 days ago

Is TransAct Technologies Incorporated (NASDAQ:TACT) Potentially Undervalued?

Solid Earnings Reflect AstraZeneca's (LON:AZN) Strength As A Business

AZN

Simply Wall St.

23 days ago

Solid Earnings Reflect AstraZeneca's (LON:AZN) Strength As A Business

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma

AZN

GlobeNewswire

24 days ago

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG)

AZN

CNW Group

25 days ago

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) and adults with generalized myasthenia gravis (gMG)

RFK Jr’s mRNA funding halt signals “shift in US public health”

AZN

Pharmaceutical Technology

25 days ago

RFK Jr’s mRNA funding halt signals “shift in US public health”

Inside AstraZeneca’s long-game strategy in lung cancer

AZN

Pharma Voice

25 days ago

Inside AstraZeneca’s long-game strategy in lung cancer

AZN

Business Wire

25 days ago

IonQ Announces Second Quarter Financial Results

AZN

Business Wire

25 days ago

Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update

AZN

PR Newswire

a month ago

Compugen Reports Second Quarter 2025 Results

AZN

MT Newswires

a month ago

US Health Department Ending Federal mRNA Vaccine Development

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

AZN

GlobeNewswire

a month ago

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Trump says pharma tariffs to start small, then soar to 250%

AZN

Reuters Videos

a month ago

Trump says pharma tariffs to start small, then soar to 250%

Trump threatens 250pc tariffs on drug imports

AZN

The Telegraph

a month ago

Trump threatens 250pc tariffs on drug imports

AZN

MT Newswires

a month ago

SOPHiA GENETICS Expanding Collaboration With AstraZeneca Focused on Breast Cancer

EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data

AZN

Benzinga

a month ago

EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

AZN

PR Newswire

a month ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

AZN

GlobeNewswire

a month ago

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

AZN

Zacks

a month ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval

AZN

GlobeNewswire

a month ago

AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen® Clinical Development Toward Pancreatic Cancer Approval

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

AZN

The Wall Street Journal

a month ago

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

AZN

CNN Business

a month ago

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

AstraZeneca Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

AZN

Simply Wall St.

a month ago

AstraZeneca Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

AZN

The Wall Street Journal

a month ago

Health Care Roundup: Market Talk

Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?

AZN

Zacks

a month ago

Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy?

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

AZN

Zacks

a month ago

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

AZN

Zacks

a month ago

Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices

AZN

The Wall Street Journal

a month ago

Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck

AZN

The Wall Street Journal

a month ago

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck

AZN

MT Newswires

a month ago

Pharma Stocks Fall Pre-Bell After Trump's Letters to Companies Over Drug Pricing

Stocks to Watch Friday: Apple, Amazon, Coinbase, Reddit

AZN

The Wall Street Journal

a month ago

Stocks to Watch Friday: Apple, Amazon, Coinbase, Reddit

European drugmakers fall after Trump raises stakes over US drug price cuts

AZN

Reuters

a month ago

European drugmakers fall after Trump raises stakes over US drug price cuts

Trump doubles down on Most Favored Nation plan to target drug prices

AZN

Pharmaceutical Technology

a month ago

Trump doubles down on Most Favored Nation plan to target drug prices

What Trump's Big Pharma CEO letters mean for drug pricing power

AZN

Yahoo Finance Video

a month ago

What Trump's Big Pharma CEO letters mean for drug pricing power

AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet

AZN

Insider Monkey

a month ago

AstraZeneca Just Missed Estimates, but Here’s Why Bulls Aren’t Worried Yet

US Expansion Not Driven By Tariffs: AstraZeneca CFO

AZN

Bloomberg

a month ago

US Expansion Not Driven By Tariffs: AstraZeneca CFO

AZN

Morningstar Research

a month ago

Analyst Report: AstraZeneca PLC

Why AstraZeneca Stock Was Topping the Market on Tuesday

AZN

Motley Fool

a month ago

Why AstraZeneca Stock Was Topping the Market on Tuesday

AstraZeneca Profit, Revenue Lifted by Cancer Drugs

AZN

Bloomberg

a month ago

AstraZeneca Profit, Revenue Lifted by Cancer Drugs

Pharma tariffs would be 'counterproductive,' industry rep. says

AZN

Yahoo Finance Video

a month ago

Pharma tariffs would be 'counterproductive,' industry rep. says

AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO

AZN

Yahoo Finance

a month ago

AstraZeneca increasing focus on US market, as it is 'first to provide access to patients': CFO

IonQ (IONQ) Names Quantum Pioneer Marco Pistoia As Senior Vice President

AZN

Simply Wall St.

a month ago

IonQ (IONQ) Names Quantum Pioneer Marco Pistoia As Senior Vice President

AZN

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

European stocks rally with eyes on earnings, trade deal

AZN

AFP

a month ago

European stocks rally with eyes on earnings, trade deal

AZN

Business Wire

a month ago

Latest AstraZeneca PLC (AZN) News on September 1, 2025

Share on Social Networks: